Advertisement

Bodily Distress Syndrome (BDS), Bodily Stress Syndrome (BSS) and Health Anxiety in Older Adults

  • Gabriel Ivbijaro
  • David Goldberg
  • Lucja Kolkiewicz
  • Todd M. Edwards
  • Clifton McReynolds
  • Igor Svab
Chapter

Abstract

Disorders of bodily distress or bodily experience occur across all age groups including older adults. Understanding this condition in older adults particularly in primary care is very important because over 25% of primary care consultations are accounted for by people who are aged 65 years and older and it significantly impacts caregivers. Treatment of BDS requires professionals from multiple disciplines who can effectively collaborate to optimize care.

Keywords

Health anxiety Bodily distress syndrome Bodily stress syndrome Older adults 

References

  1. 1.
    Creed F, Guthrie E, Fink P, Henningsen R, Reif W, Sharpe M, White P. Is there a better term than ‘medically unexplained symptoms’? J Psychosom Res. 2010;68:5–8.  https://doi.org/10.1016/j.jpsychores.2009.09.004.CrossRefPubMedGoogle Scholar
  2. 2.
    Henningsen P, Fink P, Hausteiner-Wiehle C, Reif W. Terminology, classification and concepts. In: Creed F, Henningsen P, Fink P, editors. Medically unexplained symptoms, somatisation and bodily distress. Cambridge: Cambridge University Press; 2011.Google Scholar
  3. 3.
    Salmon S, Peters S, Stanley I. Patients’ perceptions of medical explanations for somatisation disorders: qualitative analysis. Br Med J. 1999;318:372–6.CrossRefGoogle Scholar
  4. 4.
    Ivbijaro G, Goldberg D. Bodily distress syndrome (BDS): the evolution from medically unexplained symptoms (MUS). Ment Health Fam Med. 2013;10:63–4.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Edwards TM, Stern A, Clarke DD, Ivbijaro G, Kasney LM. The treatment of patients with medically unexplained symptoms in primary care: a review of the literature. Ment Health Fam Med. 2010;7:209–21.PubMedPubMedCentralGoogle Scholar
  6. 6.
    American Psychiatric Association. Somatic symptom and related disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: APA; 2013.CrossRefGoogle Scholar
  7. 7.
    Fink P, Toft T, Hansen MS, Ørnbøl E, Olesen F. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med. 2007;69:30–9.CrossRefGoogle Scholar
  8. 8.
    Fink P, Schröder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68:415–26.CrossRefGoogle Scholar
  9. 9.
    Häuser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014;18(8):1052–9.  https://doi.org/10.1002/j.1532-2149.2014.00453.x.CrossRefPubMedGoogle Scholar
  10. 10.
    Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained symptoms in primary care- a systematic review and meta-analysis of prevalence. Dtsch Arztebl Int. 2015;112:279–87.  https://doi.org/10.3238/arztebl.2015.0297.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    World Health Organization. International classification of diseases 11th revision. Geneva: WHO; 2018. https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f794195577.Google Scholar
  12. 12.
    Wijeratne C, Hickie I. Somatic distress syndromes in later life: the need for paradigm change. Psychol Med. 2001;31:571–6.CrossRefGoogle Scholar
  13. 13.
    Commonwealth Department of Health and Family Services, General Practice Branch. General practice in Australia. Canberra: Commonwealth of Australia; 1996.Google Scholar
  14. 14.
    Budtz-Lilly A, Vestergaard M, Fink M, Carlsen AH, Rosendal M. Patient characteristics and frequency of bodily distress syndrome in primary care: a cross-sectional study. Br J Gen Pract. 2015;65(638):e617–22.  https://doi.org/10.3399/bjgp15X686545.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Matwijk H. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014;11:CD011142.  https://doi.org/10.1002/14651858.CD011142.pub2.CrossRefGoogle Scholar
  16. 16.
    Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W. Antipsychtics for fibromyalgia in adults. Cochrane Database Syst Rev. 2016;6:CD011804.  https://doi.org/10.1002/14651858.CD011804.pub2.CrossRefGoogle Scholar
  17. 17.
    Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I. Combined pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev. 2018;2:CD010585.  https://doi.org/10.1002/14651858.CD010585.pub2.CrossRefPubMedGoogle Scholar
  18. 18.
    Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRI’s) for fibromyalgia. Cochrane Database Syst Rev. 2018;2:CD010292.  https://doi.org/10.1002/14651858.CD010292.pub.2.CrossRefPubMedGoogle Scholar
  19. 19.
    Funk M, Ivbijaro G (eds). Integrating mental health into primary care: a global perspective. WHO/Wonca: 2008.Google Scholar
  20. 20.
    Ivbijaro GO, Enum Y, Khan AA, Lam SS-K, Gabzdyl A. Collaborative care: models for treatment of patients with complex medical-psychiatric conditions. Curr Psychiatry Rep. 2014;16:506.CrossRefGoogle Scholar
  21. 21.
    Ivbijaro G. Mental health: a resilience factor against both NCDs and CDs. In: Commonwealth health partnerships 2012. Cambridge: Nexus Strategic Partnerships; 2012. p. 17–20.Google Scholar
  22. 22.
    Rosendal M, Blankenstein AH, Morriss R, Fink P, Sharpe M, Burton C. Enhanced care by generalists for functional somatic symptoms and disorders in primary care. Cochrane Database Syst Rev. 2013;10:CD008142.  https://doi.org/10.1002/14651858.CD008142.pub2.CrossRefGoogle Scholar
  23. 23.
    Häuser W, Ablin J, Perrot S, Fitzcharles M-A. Management of fibromyalgia: key messages from recent evidence-based guidelines. Pol Arch Intern Med. 2017;127(1):47–56.  https://doi.org/10.20452/pamw.3877.CrossRefPubMedGoogle Scholar
  24. 24.
    Petzke F, Brückle W, Eidmann U, Heldmann P, Köllner V, Kühn T, Kühn-Becker H, Strunk-Richter M, Schiltenwolf M, Settan M, von Wachter M, Weigl M, Häuser W. General treatment principles, coordination of care and patient education in fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles. Schmerz. 2017;31(3):246–54.  https://doi.org/10.1007/s00482-017-0201-6.CrossRefPubMedGoogle Scholar
  25. 25.
    McAndrew LM, Phillips LA, Helmer DA, Maesto K, Engel CC, Greenberg LM, Anastasides N, Quigley KS. High healthcare utilization near the onset of medically unexplained symptoms. J Psychosom Res. 2017;98:98–105.  https://doi.org/10.1016/jpsychores.2017.05.001.CrossRefPubMedGoogle Scholar
  26. 26.
    Rief W, Burton C, Frostholm L, Henningsen P, Kleinstäuber M, Kop WJ, Löwe B, Martin A, Malt U, Rosmalen J, Schröder A, Sheddon-Mora M, Toussaint A, van der Feltz-Cornelis C, on behalf of the EURONET-SOMA Group. Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: European Network on Somatic Symptom Disorders Recommendations. Psychosom Med. 2017;17(9):1008–15.  https://doi.org/10.1097/PSY.0000000000000502.CrossRefGoogle Scholar
  27. 27.
    Trimbos Instituut /Netherlands Institute of mental Health and Addiction. Multidisciplinaire Richtlijn SOLK en Somatoforme Stoornissen. [multidisciplinary guideline medically unexplained symptoms and somatoform disorders]. Houten: Ladenius Communicatie BV; 2010.Google Scholar
  28. 28.
    Olde Hartman TC, Rosendal M, Aamland A, van der Horst HE, Rosmalen JGM, Burton CD, Lucassen PLBJ. What do guidelines and systematic reviews tell us about the management of medically unexplained symptoms in primary care? BJGP Open. 2017;1(3):BJGP-2016-0868.  https://doi.org/10.3399/bjgpopen17X101061.CrossRefGoogle Scholar
  29. 29.
    Busch AJ, Schachter CL, Overend TJ, Peloso PM, Barber KA. Exercise for fibromyalgia: a systematic review. J Rheumatol. 2008;35(6):1130–44.PubMedGoogle Scholar
  30. 30.
    Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369(9565):946–55.CrossRefGoogle Scholar
  31. 31.
    Fink P, Rosendal M. Recent developments in the understanding and management of functional somatic symptoms in primary care. Curr Opin Psychiatry. 2008;21(2):182–8.CrossRefGoogle Scholar
  32. 32.
    Fjorback LO, Arendt M, Ørnbøl WH, rehfeld E. Mindfulness therapy for somatization disorder and functional somatic syndromes – randomized trial with one-year follow-up. J Psychosom Res. 2013;74:31–40.  https://doi.org/10.1016/j.jpsychores.2012.09.006.CrossRefPubMedGoogle Scholar
  33. 33.
    Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM, Ktol B, Stewart R, Groothoff JW. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010;12:CD006524.  https://doi.org/10.1002/14651858.CD006524.pub2.CrossRefGoogle Scholar
  34. 34.
    Payne H. The body speaks its mind: the BodyMind ApproachTM for patients with medically unexplained symptoms in primary care in England. Arts Psychother. 2015;42:19–27.  https://doi.org/10.1016/j.aip.2014012.011.CrossRefGoogle Scholar
  35. 35.
    Payne H. The BodyMind approach™: supporting people with medically unexplained symptoms/somatic symptom disorder. J Psychother Couns Psychol. Reflect. 2017;2(2):5–7.Google Scholar
  36. 36.
    Brown RJ, Schrag A, Trimble MR. Dissociation, childhood interpersonal trauma, and family functioning in patients with somatization disorder. Am J Psychiatr. 2005;162:899–905.CrossRefGoogle Scholar
  37. 37.
    Hilbert A, Martin A, Zech T, et al. Patients with medically unexplained symptoms and their significant others: illness attributions and behaviors as predictors of patient functioning over time. J Psychosom Res. 2010;68:253–62.CrossRefGoogle Scholar
  38. 38.
    Families RJ. Illness, and disability: an integrative treatment model. New York: Basic Books; 1994.Google Scholar
  39. 39.
    Watson WH, McDaniel SH. Relational therapy in medical settings: working with somatizing patients and their families. J Clin Psychol. 2000;56:1065–82.CrossRefGoogle Scholar
  40. 40.
    McDaniel H, Doherty WJ, Hepworth J. Medical family therapy and integrated care. In: 2nd edition. Washington, D.C.: American Psychological Association; 2014.Google Scholar
  41. 41.
    Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev. 2016;6:CD011804.  https://doi.org/10.1002/14651858.CD011804.pub2.CrossRefGoogle Scholar
  42. 42.
    Budtz-Lilly A, Schröder RMT, Fink P, Vestergaard M, Rosendal M. Bodily distress syndrome: a new diagnosis for functional disorders in primary care? BMC Fam Pract. 2015;16:180.  https://doi.org/10.1186/s12875-015-0393-8.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Fink P, Rosendal M, Olesen F. Classification of somatization and functional somatic symptoms in primary care. Aust N Z J Psychiatry. 2005;39:772–81.CrossRefGoogle Scholar
  44. 44.
    Budtz-Lilly A, Fink P, Ørnbøl E, Vestergaard M, Moth G, Christensen KS, Rosendal M. A new questionnaire to identify bodily distress in primary care: the ‘BDS checklist. J Psychosom Res. 2015;78:536–45.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Gabriel Ivbijaro
    • 1
    • 2
  • David Goldberg
    • 3
  • Lucja Kolkiewicz
    • 1
    • 4
  • Todd M. Edwards
    • 5
  • Clifton McReynolds
    • 6
  • Igor Svab
    • 7
  1. 1.NOVA UniversityLisbonPortugal
  2. 2.Waltham Forest Community & Family Health ServicesLondonUK
  3. 3.King’s CollegeLondonUK
  4. 4.East London NHS Foundation TrustLondonUK
  5. 5.Marital and Family Therapy ProgramUniversity of San DiegoSan DiegoUSA
  6. 6.ChicagoUSA
  7. 7.Medical FacultyUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations